The evaluation of value-based payment (VBP) models over the past decade has shown mixed results. While there have been some improvements in spending and quality, the models have not significantly advanced health outcomes or sustainable spending at scale. To drive...
While the life science industry began piloting decentralized clinical trials (DCTs) more than 15 years ago, the COVID 19 pandemic led to tremendous growth, primarily out of necessity. As the world shut down, DCTs became the only viable option for...
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Privacy Policy
